EXAS’s Market Quandary: Decoding the Ups and Downs of 2025

ZM Stock

The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price decrease of -20.00%. However, over the past six months, we’ve seen a stronger performance of -6.89%. The price of EXAS leaped by -5.68% over the last 30 days. And in the last five days, it has surged by 4.65%.

The stock price for Exact Sciences Corp (EXAS) currently stands at $47.0. The stock experienced a substantial increase in the last session, hitting $80.0 after starting at $47.0. The stock’s lowest price was $46.0 before closing at $45.68.

Exact Sciences Corp saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $72.83 on 11/05/24, while the lowest price for the same duration was marked at $38.81 on 08/07/25.

52-week price history of EXAS Stock

Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Exact Sciences Corp’s current trading price is -35.47% away from its 52-week high, while its distance from the 52-week low is 21.10%. The stock’s price range during this period has varied between$38.81 and $72.83. The Exact Sciences Corp’s shares, which operate in the Healthcare, saw a trading volume of around 3.79 million for the day, a figure considerably higher than their average daily volume of 3.22 million over last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Exact Sciences Corp (EXAS) has experienced a quarterly decline of -18.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 8.90B and boasts a workforce of 7000 employees.

Exact Sciences Corp: Analysts’ Ratings Unveiled

As of right now, 18 analysts are rating Exact Sciences Corp as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 49.91, with a change in price of +2.01. Similarly, Exact Sciences Corp recorded 3,127,703 in trading volume during the last 100 days, posting a change of +4.47%.

EXAS’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look

The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for EXAS stands at 1.03. Similarly, the long-term debt-to-equity ratio is also 1.01.

EXAS Stock Stochastic Average

As of today, Exact Sciences Corp’s raw stochastic average for the last 50 days stands at 44.05%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 73.65%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 62.49% and 56.98%, respectively.

Invest Chronicle
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.